Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Intermune Concludes Sale of Actimmune
Yahoo/Zacks
Saturday, June 23, 2012 - 11:48am
tags:
InterMune, Actimmune
Will Patience Pay for Arena’s Biggest Fans Awaiting the Final Answer?
Wall Street Cheat Street
Saturday, June 23, 2012 - 11:43am
tags:
Arena, lorcaserin, obesity, weight loss
Coronado Biosciences prices offering of 5M shares
Yahoo/AP
Saturday, June 23, 2012 - 11:42am
tags:
Coronado Biosciences
3 Rallying Drug-Makers Being Snapped Up By Insiders
Seeking Alpha
Friday, June 22, 2012 - 4:01pm
tags:
Pacira, Pharmacyclics, Ardea Biosciences
Alexza rockets 30% on FDA update
Marketwatch
Friday, June 22, 2012 - 4:00pm
tags:
Alexza, FDA, bipolar disorder, Adasuve
Why are Obesity Stocks Suddenly So Hot?
Motley Fool
Friday, June 22, 2012 - 3:52pm
tags:
obesity, lorcaserin, Arena Pharmaceuticals, Vivus, Qnexa, Orexigen, Contrave
Coronado Biosciences prices offering of 5M shares, expects proceeds of about $23M
Yahoo/AP
Friday, June 22, 2012 - 3:51pm
tags:
Coronado Biosciences, stock offering
Arena shares slump 14 pct before diet drug ruling
Reuters
Friday, June 22, 2012 - 3:46pm
tags:
Arena Pharmaceuticals, lorcaserin, FDA, obesity
NVO Candidate to Step into Phase III
Yahoo/Zacks
Friday, June 22, 2012 - 3:30pm
tags:
Novo Nordisk, semaglutide, diabetes
Wisconsin Supreme Court upholds damages awarded in Medicaid drug lawsuit
Yahoo/AP
Friday, June 22, 2012 - 3:29pm
tags:
Wisconsin, Medicaid, lawsuits, Pharmacia
Why Protalix BioTherapeutics Plunged
Motley Fool
Friday, June 22, 2012 - 3:28pm
tags:
Protalix BioTherapeutics, Pfizer, Gaucher disease
Biodel raises $18.5M in a private placement
The Fly on the Wall
Friday, June 22, 2012 - 10:31am
tags:
Biodel
Johnson & Johnson: Charges Could Damage Stock
Seeking Alpha
Friday, June 22, 2012 - 10:27am
tags:
JNJ, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Sanofi
Baxter: Another High Quality Name For Your Income Portfolio
Seeking Alpha
Friday, June 22, 2012 - 9:32am
tags:
Baxter, Affymax
Blood Pressure Drug Olmesartan Linked to Celiac Disease Side Effects in a Handful of Patients
ABC News
Friday, June 22, 2012 - 9:31am
tags:
celiac disease, Olmesartan, Benicar
Novartis' Afinitor recommended by CHMP for EU approval
Yahoo/Fly on the Wall
Friday, June 22, 2012 - 9:29am
tags:
Novartis, Afinitor, Europe, CHMP, breast cancer
Eli Lilly: New Drug Shows Strong Potential
Seeking Alpha
Friday, June 22, 2012 - 9:28am
tags:
Eli Lilly, Incyte, baricitinib, Merck, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, rheumatoid arthritis
FDA denies expanded approval of J&J blood thinner; has more questions
Yahoo/AP
Friday, June 22, 2012 - 9:26am
tags:
FDA, bloodthinners, JNJ, Xarelto
AstraZeneca Will Soar On 2 New Drugs In 2013
Seeking Alpha
Thursday, June 21, 2012 - 5:54pm
tags:
AstraZeneca, Bristol-Myers Squibb, JNJ, Eli Lilly, AZD4547, Merck, Sanofi, Dapagliflozin
Teva launches generic Symbyax in the United States
The Fly on the Wall
Thursday, June 21, 2012 - 5:51pm
tags:
generics, Teva Pharmaceuticals, Symbyax, Eli Lilly, bipolar disorder

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.